Columbia Basin Hematology & Oncology

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


SCCA Clinical Trials: Columbia Basin Hematology & Oncology

The affiliation between SCCA and Columbia Basin Hematology Oncology means patients living in southeast Washington have access to the latest cancer treatment options, including those only available in clinical trials or at a comprehensive academic cancer center, such as SCCA.

Below are the first of many SCCA clinical trials offered for patients at Columbia Basin Hematology Oncology

Breast Cancer (Newly Diagnosed)

  • Chemo w/wo Traztuzumab After Surgery for Invasive Breast Cancer (NSABP B-47)
    A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab (Herceptin) in Women with Node-Positive or High-Risk Node-Negative HER@-Low Invasive Breast Cancer
  • Hormone Therapy w/o Everolimus for Breast Cancer (SWOG 1207)
    Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer

Breast Cancer (Recurrent/Metastatic)

Gynecologic Cancer (Recurrent/Metastatic)

Leukemia

 

Lung Cancer

Lymphoma